This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,249.81 firm fixed-price delivery order, with a completion date of November 20, 2024, is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to reverse opioid overdoses.
The award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs.
Generated 2/18/25, 1:34 PM